BTQ.NEO vs. MRK

Last updated Jun 9, 2026

BTQ.NEO (BTQ Technologies Corp) and MRK (Merck & Co., Inc.) are both stocks. BTQ.NEO operates in Software - Infrastructure (Technology), while MRK operates in Drug Manufacturers - General (Healthcare). Over the past 3 years, BTQ.NEO returned 109.30%/yr vs 7.29%/yr for MRK. At a correlation of -0.03, they often move in opposite directions.

Performance

BTQ.NEO vs. MRK - Performance Comparison

The chart below illustrates the hypothetical performance of a CA$10,000 investment in BTQ Technologies Corp (BTQ.NEO) and Merck & Co., Inc. (MRK). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

BTQ.NEO is traded in CAD, while MRK is traded in USD. To make them comparable, the MRK values have been converted to CAD using the latest available exchange rates.

Returns By Period

In the year-to-date period, BTQ.NEO achieves a -15.94% return, which is significantly lower than MRK's 16.47% return.

BTQ.NEO

• 1D: 4.01%
• 1M: 41.90%
• YTD: -15.94%
• 6M: -34.79%
• 1Y: 40.24%
• 3Y*: 109.30%
• 5Y*: —
• 10Y*: —

MRK

• 1D: -0.78%
• 1M: 9.54%
• YTD: 16.47%
• 6M: 23.72%
• 1Y: 60.03%
• 3Y*: 7.29%
• 5Y*: 16.82%
• 10Y*: 12.63%

*Multi-year figures are annualized to reflect compound growth (CAGR)

BTQ.NEO vs. MRK - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023
BTQ.NEO BTQ Technologies Corp	-15.94%	79.95%	380.49%	9.33%
MRK Merck & Co., Inc.	16.47%	4.78%	1.68%	0.48%

Correlation

The correlation between BTQ.NEO and MRK is -0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.04
Correlation (3Y) Calculated over the trailing 3-year period	-0.03
Correlation (All Time) Calculated using the full available price history since Feb 21, 2023	-0.03

Fundamentals

Market Cap BTQ.NEO : CA$821.41M MRK : $295.45B
EPS BTQ.NEO : -CA$0.11 MRK : $3.58
PS Ratio BTQ.NEO : 1.42K MRK : 4.54
PB Ratio BTQ.NEO : 21.55 MRK : 6.44
Total Revenue (TTM) BTQ.NEO : CA$565.50K MRK : $65.59B
Gross Profit (TTM) BTQ.NEO : CA$565.50K MRK : $49.79B
EBITDA (TTM) BTQ.NEO : -CA$14.23M MRK : $22.69B

Return for Risk

BTQ.NEO vs. MRK — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BTQ.NEO

BTQ.NEO Risk / Return Rank: 59
BTQ.NEO Sharpe Ratio Rank: 52
BTQ.NEO Sortino Ratio Rank: 72
BTQ.NEO Omega Ratio Rank: 65
BTQ.NEO Calmar Ratio Rank: 54
BTQ.NEO Martin Ratio Rank: 51

MRK

MRK Risk / Return Rank: 90
MRK Sharpe Ratio Rank: 90
MRK Sortino Ratio Rank: 90
MRK Omega Ratio Rank: 86
MRK Calmar Ratio Rank: 92
MRK Martin Ratio Rank: 91

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BTQ.NEO vs. MRK - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for BTQ Technologies Corp (BTQ.NEO) and Merck & Co., Inc. (MRK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	BTQ.NEO	MRK	Difference
Sharpe ratio: Return per unit of total volatility	0.25	2.17	-1.92
Sortino ratio: Return per unit of downside risk	1.77	3.10	-1.33
Omega ratio: Gain probability vs. loss probability	1.18	1.37	-0.19
Calmar ratio: Return relative to maximum drawdown	0.48	4.84	-4.36
Martin ratio: Return relative to average drawdown	0.69	12.33	-11.65
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

BTQ.NEO vs. MRK - Sharpe Ratio Comparison

The current BTQ.NEO Sharpe Ratio is 0.25, which is lower than the MRK Sharpe Ratio of 2.17. The chart below compares the historical Sharpe Ratios of BTQ.NEO and MRK, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	BTQ.NEO	MRK	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.25	2.17	-1.92
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.69	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.53	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.52	0.30	+0.23

Drawdowns

BTQ.NEO vs. MRK - Drawdown Comparison

The maximum BTQ.NEO drawdown since its inception was -84.85%, which is greater than MRK's maximum drawdown of -56.15%. Use the drawdown chart below to compare losses from any high point for BTQ.NEO and MRK.

Drawdown Indicators

	BTQ.NEO	MRK	Difference
Max Drawdown Largest peak-to-trough decline	-84.85%	-56.15%	-28.70%
Max Drawdown (1Y) Largest decline over 1 year	-84.85%	-12.46%	-72.39%
Max Drawdown (3Y) Largest decline over 3 years	-84.85%	-42.49%	-42.36%
Max Drawdown (5Y) Largest decline over 5 years	—	-42.49%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-42.49%	—
Current Drawdown Current decline from peak	-69.90%	-2.96%	-66.94%
Average Drawdown Average peak-to-trough decline	-46.92%	-17.81%	-29.11%
Ulcer Index Depth and duration of drawdowns from previous peaks	59.20%	4.88%	+54.32%

Volatility

BTQ.NEO vs. MRK - Volatility Comparison

BTQ Technologies Corp (BTQ.NEO) has a higher volatility of 42.21% compared to Merck & Co., Inc. (MRK) at 9.61%. This indicates that BTQ.NEO's price experiences larger fluctuations and is considered to be riskier than MRK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BTQ.NEO	MRK	Difference
Volatility (1M) Calculated over the trailing 1-month period	42.21%	9.61%	+32.60%
Volatility (6M) Calculated over the trailing 6-month period	85.04%	18.85%	+66.19%
Volatility (1Y) Calculated over the trailing 1-year period	161.33%	27.84%	+133.49%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	172.04%	24.67%	+147.37%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	172.04%	23.93%	+148.11%

Dividends

BTQ.NEO vs. MRK - Dividend Comparison

BTQ.NEO has not paid dividends to shareholders, while MRK's dividend yield for the trailing twelve months is around 2.78%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
BTQ.NEO BTQ Technologies Corp	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
MRK Merck & Co., Inc.	2.78%	3.12%	3.14%	2.72%	2.52%	3.41%	3.03%	2.48%	2.60%	3.36%	3.14%	3.43%

Financials

Frequently Asked Questions

Can I hold both BTQ.NEO and MRK in my portfolio?

BTQ.NEO and MRK have a correlation of -0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.